SCHEMBL7716574

SCHEMBL7716574

Nc1ncc(Oc2cccc(Cl)c2)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
CYP2D6 P10635 1/20 0.53
LMNA P02545 3/20 0.46
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
DYRK3 O43781 1/20 0.43
CCNT1 O60563 1/20 0.43
CDK9 P50750 1/20 0.43
DYRK1A Q13627 1/20 0.43
DYRK2 Q92630 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
DRD2 P14416 2/20 0.42
HTR1A P08908 1/20 0.42
HTR7 P34969 1/20 0.42
HTR6 P50406 1/20 0.42
DHFR P00374 1/20 0.41
MEN1 O00255 1/20 0.41
ROCK2 O75116 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708539 0.88 MAPT (0.51) KMT2ALMNATP53SMN1; SMN2HTT
SCHEMBL7714564 0.88 HRH4 (0.43) KMT2ADRD2HTR1AHTR7HTR6
SCHEMBL7714357 0.88 HTR3E (0.43) KMT2ACYP2D6LMNASMN1; SMN2DRD2
SCHEMBL7708442 0.87 LMNA (0.45) KMT2ACYP2D6LMNATP53SMN1; SMN2
SCHEMBL7708465 0.84 HTR7 (0.43) KMT2ACYP2D6LMNATP53SMN1; SMN2
SCHEMBL7712407 0.83 HTR1A (0.46) LMNATP53SMN1; SMN2MAPK1HTT
SCHEMBL7708476 0.83 ROCK2 (0.40) KMT2ACYP2D6LMNATP53SMN1; SMN2
SCHEMBL7712404 0.82 METAP1 (0.44) LMNATP53HTTDRD2HTR1A
SCHEMBL7714186 0.81 KMT2A (0.48) KMT2ALMNATP53DHFRMEN1
SCHEMBL7714566 0.81 ROCK2 (0.41) HTTHTR1AROCK2ROCK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed